Structure Therapeutics Inc. (GPCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.12B |
| Enterprise Value | 3.32B |
| P/E Ratio | -5.37 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.25 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.22 |
| Return On Equity | -0.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -3.9M |
| EBITDA | -139.35M |
| Net Income | -141.2M |
| Diluted EPS | -2.4 |
| Total Cash | 1.24B |
| Total Cash/Share | 17.02 |
| Total Debt | 6.83M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 11.91 |
| Book Value Per Share | 16.77 |
| 52-Week Change | -41.68 |
| 52-Week High | 94.9 |
| 52-Week Low | 18.7 |
| Moving Average 50 Days | 28.99 |
| Moving Average 200 Days | 46.28 |
| Average Volume | 1.15M |
| Shares Outstanding | 57.57M |
| % Held by Institutions | 92.99 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |